![James E. Pitts](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
James E.
Pitts is currently the Director at Abeome Corp.
since 2009.
Prior to this, he worked as a Principal at Randcor, Inc.
Aktive Positionen von James E. Pitts
Unternehmen | Position | Beginn |
---|---|---|
Abeome Corp.
![]() Abeome Corp. BiotechnologyHealth Technology Abeome Corp. operates as a biotechnology company. It develops therapeutic and diagnostic monoclonal antibodies (mAbs). The firm’s DiSH (Direct Selection of Hybridomas) technology offers a process for selecting and cloning desired hybridomas that produce antibodies with optimal binding characteristics. The company was founded by Richard B. Meagher in 2000 and is headquartered in Athens, GA. | Direktor/Vorstandsmitglied | 18.11.2009 |
Ehemalige bekannte Positionen von James E. Pitts
Unternehmen | Position | Ende |
---|---|---|
Randcor, Inc. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Abeome Corp.
![]() Abeome Corp. BiotechnologyHealth Technology Abeome Corp. operates as a biotechnology company. It develops therapeutic and diagnostic monoclonal antibodies (mAbs). The firm’s DiSH (Direct Selection of Hybridomas) technology offers a process for selecting and cloning desired hybridomas that produce antibodies with optimal binding characteristics. The company was founded by Richard B. Meagher in 2000 and is headquartered in Athens, GA. | Health Technology |
Randcor, Inc. |